HISTORY
- 2022
-
-
06
Attraction of USD 4 million Pre-series A
-
06
- 2021
-
-
09
Certification of LMO (Living Modified Organism) Lab
-
07
Acquisition of R&D Center certification
-
05
Attraction of USD 1.4 million Seed funding
-
03
Establishment of D5 Therapeutics
-
09